Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib extension study in patients with cancer benefiting from prior iniparib treatment
2011-006246-33Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in cancer, Nonhematologic neoplasms, sponsored by Sanofi. Started Mar 2012; status: completed.
02
Drugs
iniparib
03
Conditions
cancerNonhematologic neoplasms
Beyond the preview
Go deeper on 2011-006246-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006246-33.